AI-Assisted COPD Diagnosis Under the GOLD 2026 Framework: A Narrative Review of Opportunities, Evidence Gaps, and Implementation Pathways

Phalguni Deswal

Independent Researcher, India.

Abstract

Chronic obstructive pulmonary disease (COPD) is still widely underdiagnosed, misdiagnosed, and diagnosed late, mainly because spirometry is underused and often poorly performed or interpreted. The 2026 report of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) keeps post-bronchodilator spirometry as the diagnostic anchor, but it adds targeted case finding, opportunistic detection through lung cancer screening, a clearer role for computed tomography, the concept of disease activity and, for the first time, a chapter on artificial intelligence (AI) and emerging technologies. This narrative review examines how AI could support COPD diagnosis within that framework and how far the published evidence actually goes. The paper mapped studies across five data streams: spirometry quality control and interpretation; chest computed tomography; chest radiographs and electrocardiograms; physiological and acoustic signals; and electronic health records, including large language models. The most mature evidence concerns spirometry interpretation software and deep learning on computed tomography, where several models show good discrimination and some external validation. Most other approaches remain at the stage of retrospective development in small or selected samples. Common weaknesses across modalities include reference standards that do not match the GOLD definition, label noise from diagnostic codes, spectrum bias, poor reporting of calibration, scarce data from low- and middle-income countries, and an almost complete absence of prospective studies with patient-relevant outcomes. The paper proposes a staged implementation pathway in which AI works as a triage and quality layer that sends the right people to confirmatory spirometry rather than replacing it. This should be supported by local validation, monitoring for dataset shift, equity audits, and AI-specific reporting standards. Pragmatic trials measuring diagnostic yield, time to diagnosis, and downstream care are now the priority.

Keywords: Chronic obstructive pulmonary disease; GOLD 2026; Artificial intelligence; Spirometry; Case finding; Quantitative computed tomography

References

  1. Aaron, S.D., Montes de Oca, M., Celli, B., et al. (2024a) ‘Early diagnosis and treatment of chronic obstructive pulmonary disease: the costs and benefits of case finding’, American Journal of Respiratory and Critical Care Medicine, 209, pp. 928-937. https://doi.org/10.1164/rccm.202311-2120PP
  2. Aaron, S.D., Vandemheen, K.L., Whitmore, G.A., et al. (2024b) ‘Early diagnosis and treatment of COPD and asthma – a randomized, controlled trial’, New England Journal of Medicine, 390, pp. 2061-2073. https://doi.org/10.1056/NEJMoa2401389
  3. Adeloye, D., Song, P., Zhu, Y., et al. (2022) ‘Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis’, The Lancet Respiratory Medicine, 10(5), pp. 447-458. https://doi.org/10.1016/S2213-2600(21)00511-7
  4. Agusti, A. and Faner, R. (2019) ‘Lung function trajectories in health and disease’, The Lancet Respiratory Medicine, 7, pp. 358-364. https://doi.org/10.1016/S2213-2600(18)30529-0
  5. Agustí, A., Celli, B.R., Criner, G.J., et al. (2023) ‘Global Initiative for Chronic Obstructive Lung Disease 2023 report: GOLD executive summary’, European Respiratory Journal, 61(4), 2300239. https://doi.org/10.1183/13993003.00239-2023
  6. Agustí, A., Aliberti, S., Blasi, F., et al. (2025) ‘Occluding mucous airway plugs in patients with obstructive lung diseases: a new treatable trait?’, ERJ Open Research, 11, 00793-2024. https://doi.org/10.1183/23120541.00793-2024
  7. Agusti, A., Vila, M., Faner, R., et al. (2026) ‘How artificial intelligence could improve the diagnosis and management of chronic obstructive pulmonary disease: a perspective from GOLD’, American Journal of Respiratory and Critical Care Medicine, 212(11), pp. 2736-2744. https://doi.org/10.1093/ajrccm/aamag337
  8. Akgün, K.M., Sigel, K., Cheung, K.H., et al. (2020) ‘Extracting lung function measurements to enhance phenotyping of chronic obstructive pulmonary disease (COPD) in an electronic health record using automated tools’, PLoS One, 15, e0227730. https://doi.org/10.1371/journal.pone.0227730
  9. Angelini, E.D., Yang, J., Balte, P.P., et al. (2023) ‘Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans’, Thorax, 78, pp. 1067-1079. https://doi.org/10.1136/thorax-2022-219158
  10. Avian, C., Mahali, M.I., Putro, N.A.S., et al. (2022) ‘Fx-Net and PureNet: convolutional neural network architecture for discrimination of chronic obstructive pulmonary disease from smokers and healthy subjects through electronic nose signals’, Computers in Biology and Medicine, 148, 105913. https://doi.org/10.1016/j.compbiomed.2022.105913
  11. Ayers, J.W., Poliak, A., Dredze, M., et al. (2023) ‘Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum’, JAMA Internal Medicine, 183, pp. 589-596. https://doi.org/10.1001/jamainternmed.2023.1838
  12. Baethge, C., Goldbeck-Wood, S. and Mertens, S. (2019) ‘SANRA—a scale for the quality assessment of narrative review articles’, Research Integrity and Peer Review, 4, 5. https://doi.org/10.1186/s41073-019-0064-8
  13. Bhakta, N.R., Bime, C., Kaminsky, D.A., et al. (2023) ‘Race and ethnicity in pulmonary function test interpretation: an official American Thoracic Society statement’, American Journal of Respiratory and Critical Care Medicine, 207(8), pp. 978-995. https://doi.org/10.1164/rccm.202302-0310ST
  14. Bhatt, S.P., Abadi, E., Anzueto, A., et al. (2025) ‘A multidimensional diagnostic approach for chronic obstructive pulmonary disease’, JAMA, 333(24), pp. 2164-2175. https://doi.org/10.1001/jama.2025.7358
  15. Bibault, J.E. and Xing, L. (2020) ‘Screening for chronic obstructive pulmonary disease with artificial intelligence’, The Lancet Digital Health, 2, pp. e216-e217. https://doi.org/10.1016/S2589-7500(20)30076-5
  16. Bowerman, C., Bhakta, N.R., Brazzale, D., et al. (2023) ‘A race-neutral approach to the interpretation of lung function measurements’, American Journal of Respiratory and Critical Care Medicine, 207(6), pp. 768-774. https://doi.org/10.1164/rccm.202205-0963OC
  17. Buist, A.S., McBurnie, M.A., Vollmer, W.M., et al. (2007) ‘International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study’, The Lancet, 370(9589), pp. 741-750. https://doi.org/10.1016/S0140-6736(07)61377-4
  18. Calverley, P.M.A. (2025) ‘Do you believe in magic? Computed tomography, artificial intelligence, and chronic obstructive pulmonary disease’, American Journal of Respiratory and Critical Care Medicine, 211, pp. 1112-1113. https://doi.org/10.1164/rccm.202502-0521ED
  19. Castaldi, P.J., Boueiz, A., Yun, J., et al. (2020) ‘Machine learning characterization of COPD subtypes: insights from the COPDGene study’, Chest, 157, pp. 1147-1157. https://doi.org/10.1016/j.chest.2019.11.039
  20. Cazzola, M., Bajpai, J., Calzetta, L., et al. (2026) ‘GOLD 2026: transforming COPD management with early intervention, multi-dimensional assessment, and personalized care’, Drugs, 86, pp. 581-597. https://doi.org/10.1007/s40265-026-02303-3
  21. Chen, W., Sin, D.D., FitzGerald, J.M., et al. (2020) ‘An individualized prediction model for long-term lung function trajectory and risk of COPD in the general population’, Chest, 157, pp. 547-557. https://doi.org/10.1016/j.chest.2019.09.003
  22. Chen, Z., Hao, J., Sun, H., et al. (2025) ‘Applications of digital health technologies and artificial intelligence algorithms in COPD: systematic review’, BMC Medical Informatics and Decision Making, 25, 77. https://doi.org/10.1186/s12911-025-02870-7
  23. Christenson, S.A., Smith, B.M., Bafadhel, M., et al. (2022) ‘Chronic obstructive pulmonary disease’, The Lancet, 399(10342), pp. 2227-2242. https://doi.org/10.1016/S0140-6736(22)00470-6
  24. Collins, G.S., Moons, K.G.M., Dhiman, P., et al. (2024) ‘TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods’, BMJ, 385, e078378. https://doi.org/10.1136/bmj-2023-078378
  25. Cosentino, J., Behsaz, B., Alipanahi, B., et al. (2023) ‘Inference of chronic obstructive pulmonary disease with deep learning on raw spirograms identifies new genetic loci and improves risk models’, Nature Genetics, 55, pp. 787-795. https://doi.org/10.1038/s41588-023-01372-4
  26. Cruz Rivera, S., Liu, X., Chan, A.W., et al. (2020) ‘Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension’, Nature Medicine, 26, pp. 1351-1363. https://doi.org/10.1038/s41591-020-1037-7
  27. Das, N., Topalovic, M. and Janssens, W. (2018) ‘Artificial intelligence in diagnosis of obstructive lung disease: current status and future potential’, Current Opinion in Pulmonary Medicine, 24, pp. 117-123. https://doi.org/10.1097/MCP.0000000000000459
  28. Das, N., Verstraete, K., Stanojevic, S., et al. (2020) ‘Deep-learning algorithm helps to standardise ATS/ERS spirometric acceptability and usability criteria’, European Respiratory Journal, 56, 2000603. https://doi.org/10.1183/13993003.00603-2020
  29. Das, N., Happaerts, S., Gyselinck, I., et al. (2023) ‘Collaboration between explainable artificial intelligence and pulmonologists improves the accuracy of pulmonary function test interpretation’, European Respiratory Journal, 61, 2201720. https://doi.org/10.1183/13993003.01720-2022
  30. Diab, N., Gershon, A.S., Sin, D.D., et al. (2018) ‘Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease’, American Journal of Respiratory and Critical Care Medicine, 198, pp. 1130-1139. https://doi.org/10.1164/rccm.201804-0621CI
  31. European Parliament and Council of the European Union (2024) Regulation (EU) 2024/1689 laying down harmonised rules on artificial intelligence (Artificial Intelligence Act). Official Journal of the European Union, L series, Publications Office of the European Union, Luxembourg. https://eur-lex.europa.eu/eli/reg/2024/1689/oj
  32. Finlayson, S.G., Subbaswamy, A., Singh, K., et al. (2021) ‘The clinician and dataset shift in artificial intelligence’, New England Journal of Medicine, 385, pp. 283-286. https://doi.org/10.1056/NEJMc2104626
  33. Friedman, S.H., Long, K.J., Sexauer, S., et al. (2024) ‘Role of artificial intelligence in assisting pulmonary and critical care clinical decision-making’, American Journal of Respiratory and Critical Care Medicine, 210, pp. 662-664. https://doi.org/10.1164/rccm.202402-0331RR
  34. Gawlitza, J., Sturm, T., Spohrer, K., et al. (2019) ‘Predicting pulmonary function testing from quantified computed tomography using machine learning algorithms in patients with COPD’, Diagnostics, 9, 33. https://doi.org/10.3390/diagnostics9010033
  35. Gerstein, E., Bierbrier, J., Whitmore, G.A., et al. (2023) ‘Impact of undiagnosed chronic obstructive pulmonary disease and asthma on symptoms, quality of life, healthcare use, and work productivity’, American Journal of Respiratory and Critical Care Medicine, 208, pp. 1271-1282. https://doi.org/10.1164/rccm.202307-1264OC
  36. Global Initiative for Chronic Obstructive Lung Disease (2025a) Global strategy for prevention, diagnosis and management of COPD: 2026 report. Version 1.3, Global Initiative for Chronic Obstructive Lung Disease, Deer Park, IL, USA. https://goldcopd.org/wp-content/uploads/2026/01/GOLD-REPORT-2026-v1.3-8Dec2025_WMV2.pdf
  37. Global Initiative for Chronic Obstructive Lung Disease (2025b) GOLD report 2026: key changes summary. Global Initiative for Chronic Obstructive Lung Disease, Deer Park, IL, USA. https://goldcopd.org/wp-content/uploads/2025/11/KEY-CHANGES-GOLD-2026-10Nov2025.pdf
  38. Glyde, H.M.G., Morgan, C., Wilkinson, T.M.A., et al. (2024) ‘Remote patient monitoring and machine learning in acute exacerbations of chronic obstructive pulmonary disease: dual systematic literature review and narrative synthesis’, Journal of Medical Internet Research, 26, e52143. https://doi.org/10.2196/52143
  39. Gonzalez, G., Ash, S.Y., Vegas-Sánchez-Ferrero, G., et al. (2018) ‘Disease staging and prognosis in smokers using deep learning in chest computed tomography’, American Journal of Respiratory and Critical Care Medicine, 197, pp. 193-203. https://doi.org/10.1164/rccm.201705-0860OC
  40. Graham, B.L., Steenbruggen, I., Miller, M.R., et al. (2019) ‘Standardization of spirometry 2019 update: an official American Thoracic Society and European Respiratory Society technical statement’, American Journal of Respiratory and Critical Care Medicine, 200(8), pp. e70-e88. https://doi.org/10.1164/rccm.201908-1590ST
  41. Greenhalgh, T., Wherton, J., Papoutsi, C., et al. (2017) ‘Beyond adoption: a new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies’, Journal of Medical Internet Research, 19(11), e367. https://doi.org/10.2196/jmir.8775
  42. Han, M.K., Agusti, A., Celli, B.R., et al. (2021) ‘From GOLD 0 to pre-COPD’, American Journal of Respiratory and Critical Care Medicine, 203(4), pp. 414-423. https://doi.org/10.1164/rccm.202008-3328PP
  43. Healio (2026) 2027 GOLD report discusses CT use, nonpharmacological treatments, CVD in COPD. Healio Pulmonology news report, 9 November 2026, Healio, Thorofare, NJ, USA. https://www.healio.com/news/pulmonology/20261109/2027-gold-report-discusses-ct-use-nonpharmacological-treatments-cvd-in-copd
  44. Hoesterey, D., Das, N., Janssens, W., et al. (2019) ‘Spirometric indices of early airflow impairment in individuals at risk of developing COPD: spirometry beyond FEV1/FVC’, Respiratory Medicine, 156, pp. 58-68. https://doi.org/10.1016/j.rmed.2019.08.004
  45. Humphries, S.M., Notary, A.M., Centeno, J.P., et al. (2020) ‘Deep learning enables automatic classification of emphysema pattern at CT’, Radiology, 294, pp. 434-444. https://doi.org/10.1148/radiol.2019191022
  46. Idrisoglu, A., Dallora, A.L., Cheddad, A., et al. (2024) ‘COPDVD: automated classification of chronic obstructive pulmonary disease on a new collected and evaluated voice dataset’, Artificial Intelligence in Medicine, 156, 102953. https://doi.org/10.1016/j.artmed.2024.102953
  47. Kelly, C.J., Karthikesalingam, A., Suleyman, M., et al. (2019) ‘Key challenges for delivering clinical impact with artificial intelligence’, BMC Medicine, 17, 195. https://doi.org/10.1186/s12916-019-1426-2
  48. Khor, Y.H., Poberezhets, V., Buhr, R.G., et al. (2025) ‘Assessment of home-based monitoring in adults with chronic lung disease: an official American Thoracic Society research statement’, American Journal of Respiratory and Critical Care Medicine, 211, pp. 174-193. https://doi.org/10.1164/rccm.202410-2080ST
  49. Koo, H.K., Jin, K.N., Kim, D.K., et al. (2016) ‘Association of incidental emphysema with annual lung function decline and future development of airflow limitation’, International Journal of Chronic Obstructive Pulmonary Disease, 11, pp. 161-166. https://doi.org/10.2147/COPD.S96809
  50. Labaki, W.W., Agusti, A., Bhatt, S.P., et al. (2024) ‘Leveraging computed tomography imaging to detect chronic obstructive pulmonary disease and concomitant chronic diseases’, American Journal of Respiratory and Critical Care Medicine, 210, pp. 281-287. https://doi.org/10.1164/rccm.202402-0407PP
  51. Li, X., Lin, Y., He, W., et al. (2025) ‘Enhancing the interpretation of spirometry: joint utilization of n-order adaptive Fourier decomposition and deep learning techniques’, IEEE Transactions on Instrumentation and Measurement, 74, pp. 1-14. https://doi.org/10.1109/TIM.2025.3557112
  52. Lin, F., Zhang, Z., Wang, J., et al. (2025) ‘AutoCOPD – a novel and practical machine learning model for COPD detection using whole-lung inspiratory quantitative CT measurements: a retrospective, multicenter study’, eClinicalMedicine, 82, 103166. https://doi.org/10.1016/j.eclinm.2025.103166
  53. Liu, X., Faes, L., Kale, A.U., et al. (2019) ‘A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis’, The Lancet Digital Health, 1(6), pp. e271-e297. https://doi.org/10.1016/S2589-7500(19)30123-2
  54. Liu, X., Cruz Rivera, S., Moher, D., et al. (2020) ‘Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension’, Nature Medicine, 26, pp. 1364-1374. https://doi.org/10.1038/s41591-020-1034-x
  55. Martinez, F.J., Agusti, A., Celli, B.R., et al. (2022) ‘Treatment trials in young patients with chronic obstructive pulmonary disease and pre-chronic obstructive pulmonary disease patients: time to move forward’, American Journal of Respiratory and Critical Care Medicine, 205, pp. 275-287. https://doi.org/10.1164/rccm.202107-1663SO
  56. Martinez, F.J., Han, M.K., Lopez, C., et al. (2023) ‘Discriminative accuracy of the CAPTURE tool for identifying chronic obstructive pulmonary disease in US primary care settings’, JAMA, 329(6), pp. 490-501. https://doi.org/10.1001/jama.2023.0128
  57. Mayr, W., Triantafyllopoulos, A., Batliner, A., et al. (2025) ‘Assessing the clinical and functional status of COPD patients using speech analysis during and after exacerbation’, International Journal of Chronic Obstructive Pulmonary Disease, 20, pp. 137-147. https://doi.org/10.2147/COPD.S480842
  58. Mei, S., Li, X., Zhou, Y., et al. (2025) ‘Deep learning for detecting and early predicting chronic obstructive pulmonary disease from spirogram time series’, npj Systems Biology and Applications, 11, 18. https://doi.org/10.1038/s41540-025-00489-y
  59. Melén, E., Faner, R., Allinson, J.P., et al. (2024) ‘Lung-function trajectories: relevance and implementation in clinical practice’, The Lancet, 403, pp. 1494-1503. https://doi.org/10.1016/S0140-6736(24)00016-3
  60. Mets, O.M., Buckens, C.F.M., Zanen, P., et al. (2011) ‘Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans’, JAMA, 306(16), pp. 1775-1781. https://doi.org/10.1001/jama.2011.1531
  61. Moslemi, A., Makimoto, K., Tan, W.C., et al. (2023) ‘Quantitative CT lung imaging and machine learning improves prediction of emergency room visits and hospitalizations in COPD’, Academic Radiology, 30, pp. 707-716. https://doi.org/10.1016/j.acra.2022.05.009
  62. Nagendran, M., Chen, Y., Lovejoy, C.A., et al. (2020) ‘Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies’, BMJ, 368, m689. https://doi.org/10.1136/bmj.m689
  63. Nikolaou, V., Massaro, S., Garn, W., et al. (2021) ‘Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss’, BMJ Open Respiratory Research, 8, e000980. https://doi.org/10.1136/bmjresp-2021-000980
  64. Obermeyer, Z., Powers, B., Vogeli, C., et al. (2019) ‘Dissecting racial bias in an algorithm used to manage the health of populations’, Science, 366(6464), pp. 447-453. https://doi.org/10.1126/science.aax2342
  65. Omiye, J.A., Lester, J.C., Spichak, S., et al. (2023) ‘Large language models propagate race-based medicine’, npj Digital Medicine, 6, 195. https://doi.org/10.1038/s41746-023-00939-z
  66. Pistelli, F., Sherrill, D.L., Di Pede, F., et al. (2024) ‘Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up’, Pulmonology, 30, pp. 546-554. https://doi.org/10.1016/j.pulmoe.2022.09.001
  67. Qu, S., Feng, E., Dong, D., et al. (2025) ‘Early screening of lung function by electrical impedance tomography in people with normal spirometry reveals unrecognized pathological features’, Nature Communications, 16, 622. https://doi.org/10.1038/s41467-024-55505-2
  68. Quanjer, P.H., Stanojevic, S., Cole, T.J., et al. (2012) ‘Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations’, European Respiratory Journal, 40(6), pp. 1324-1343. https://doi.org/10.1183/09031936.00080312
  69. Regan, E.A., Lynch, D.A., Curran-Everett, D., et al. (2015) ‘Clinical and radiologic disease in smokers with normal spirometry’, JAMA Internal Medicine, 175(9), pp. 1539-1549. https://doi.org/10.1001/jamainternmed.2015.2735
  70. Ritchie, A.I., Donaldson, G.C., Hoffman, E.A., et al. (2024) ‘Structural predictors of lung function decline in young smokers with normal spirometry’, American Journal of Respiratory and Critical Care Medicine, 209(10), pp. 1208-1218. https://doi.org/10.1164/rccm.202307-1203OC
  71. Schroeder, J.D., Bigolin Lanfredi, R., Li, T., et al. (2020) ‘Prediction of obstructive lung disease from chest radiographs via deep learning trained on pulmonary function data’, International Journal of Chronic Obstructive Pulmonary Disease, 15, pp. 3455-3466. https://doi.org/10.2147/COPD.S279850
  72. Sendak, M.P., Gao, M., Brajer, N., et al. (2020) ‘Presenting machine learning model information to clinical end users with model facts labels’, npj Digital Medicine, 3, 41. https://doi.org/10.1038/s41746-020-0253-3
  73. Singh, D., Stockley, R., Anzueto, A., et al. (2025) ‘GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD’, European Respiratory Journal, 65(2), 2401603. https://doi.org/10.1183/13993003.01603-2024
  74. Singhal, K., Azizi, S., Tu, T., et al. (2023) ‘Large language models encode clinical knowledge’, Nature, 620, pp. 172-180. https://doi.org/10.1038/s41586-023-06291-2
  75. Smith, L.A., Oakden-Rayner, L., Bird, A., et al. (2023) ‘Machine learning and deep learning predictive models for long-term prognosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis’, The Lancet Digital Health, 5, pp. e872-e881. https://doi.org/10.1016/S2589-7500(23)00177-2
  76. Spetrini, R., Pikman, P., Kang, V., et al. (2025) ‘Prospective COPD case finding in a lung cancer screening program: a pilot study’, Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 12, pp. 411-418. https://doi.org/10.15326/jcopdf.2025.0636
  77. Stanojevic, S., Kaminsky, D.A., Miller, M.R., et al. (2022) ‘ERS/ATS technical standard on interpretive strategies for routine lung function tests’, European Respiratory Journal, 60(1), 2101499. https://doi.org/10.1183/13993003.01499-2021
  78. Stolz, D., Mkorombindo, T., Schumann, D.M., et al. (2022) ‘Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission’, The Lancet, 400(10356), pp. 921-972. https://doi.org/10.1016/S0140-6736(22)01273-9
  79. Sun, J., Liao, X., Yan, Y., et al. (2022) ‘Detection and staging of chronic obstructive pulmonary disease using a computed tomography-based weakly supervised deep learning approach’, European Radiology, 32, pp. 5319-5329. https://doi.org/10.1007/s00330-022-08632-7
  80. Sunjaya, A., Edwards, G.D., Harvey, J., et al. (2025) ‘Validation of artificial intelligence spirometry diagnostic support software in primary care: a blinded diagnostic accuracy study’, ERJ Open Research, 11(5), 00116-2025. https://doi.org/10.1183/23120541.00116-2025
  81. Tang, L.Y.W., Coxson, H.O., Lam, S., et al. (2020) ‘Towards large-scale case-finding: training and validation of residual networks for detection of chronic obstructive pulmonary disease using low-dose CT’, The Lancet Digital Health, 2, pp. e259-e267. https://doi.org/10.1016/S2589-7500(20)30064-9
  82. Thirunavukarasu, A.J., Ting, D.S.J., Elangovan, K., et al. (2023) ‘Large language models in medicine’, Nature Medicine, 29, pp. 1930-1940. https://doi.org/10.1038/s41591-023-02448-8
  83. Tirelli, C., Mira, S., Italia, M., et al. (2025) ‘Applications of forced oscillatory technique in obstructive and restrictive pulmonary diseases: a concise state of the art’, Journal of Clinical Medicine, 14, 5718. https://doi.org/10.3390/jcm14165718
  84. Topalovic, M., Das, N., Burgel, P.R., et al. (2019) ‘Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests’, European Respiratory Journal, 53(4), 1801660. https://doi.org/10.1183/13993003.01660-2018
  85. Topol, E.J. (2019) ‘High-performance medicine: the convergence of human and artificial intelligence’, Nature Medicine, 25, pp. 44-56. https://doi.org/10.1038/s41591-018-0300-7
  86. Ueda, D., Matsumoto, T., Yamamoto, A., et al. (2024) ‘A deep learning-based model to estimate pulmonary function from chest X-rays: multi-institutional model development and validation study in Japan’, The Lancet Digital Health, 6, pp. e580-e588. https://doi.org/10.1016/S2589-7500(24)00113-4
  87. Vaid, A., Sharma, J., Jiang, J., et al. (2026) ‘Automated diagnosis of chronic obstructive pulmonary disease using deep learning applied to electrocardiograms’, eBioMedicine, 123, 106066. https://doi.org/10.1016/j.ebiom.2025.106066
  88. Vasey, B., Nagendran, M., Campbell, B., et al. (2022) ‘Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI’, Nature Medicine, 28, pp. 924-933. https://doi.org/10.1038/s41591-022-01772-9
  89. Venkatesan, P. (2025) ‘GOLD COPD report: 2026 update’, The Lancet Respiratory Medicine, 14, pp. e14-e15. https://doi.org/10.1016/S2213-2600(25)00432-1
  90. Vila, M., Sisó-Almirall, A., Ocaña, A., et al. (2025) ‘Prevalence, diagnostic accuracy, and healthcare utilization patterns in patients with COPD in primary healthcare: a population-based study’, npj Primary Care Respiratory Medicine, 35, 17. https://doi.org/10.1038/s41533-025-00419-9
  91. Wang, M., Li, L., Feng, M., et al. (2025) ‘Advances in artificial intelligence applications for the management of chronic obstructive pulmonary disease’, Frontiers in Medicine, 12, 1685254. https://doi.org/10.3389/fmed.2025.1685254
  92. Wang, Y., Li, Q., Chen, W., et al. (2022a) ‘Deep learning-based analytic models based on flow-volume curves for identifying ventilatory patterns’, Frontiers in Physiology, 13, 824000. https://doi.org/10.3389/fphys.2022.824000
  93. Wang, Y., Li, Y., Chen, W., et al. (2022b) ‘Deep learning for automatic upper airway obstruction detection by analysis of flow-volume curve’, Respiration, 101, pp. 841-850. https://doi.org/10.1159/000524598
  94. Wang, Y., Li, Y., Chen, W., et al. (2022c) ‘Deep learning for spirometry quality assurance with spirometric indices and curves’, Respiratory Research, 23, 98. https://doi.org/10.1186/s12931-022-02014-9
  95. Wijnant, S.R.A., De Roos, E., Kavousi, M., et al. (2020) ‘Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study’, European Respiratory Journal, 55(1), 1901217. https://doi.org/10.1183/13993003.01217-2019
  96. Wolff, R.F., Moons, K.G.M., Riley, R.D., et al. (2019) ‘PROBAST: a tool to assess the risk of bias and applicability of prediction model studies’, Annals of Internal Medicine, 170(1), pp. 51-58. https://doi.org/10.7326/M18-1376
  97. Wong, A., Otles, E., Donnelly, J.P., et al. (2021) ‘External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients’, JAMA Internal Medicine, 181(8), pp. 1065-1070. https://doi.org/10.1001/jamainternmed.2021.2626
  98. Woodruff, P.G., Barr, R.G., Bleecker, E., et al. (2016) ‘Clinical significance of symptoms in smokers with preserved pulmonary function’, New England Journal of Medicine, 374(19), pp. 1811-1821. https://doi.org/10.1056/NEJMoa1505971
  99. World Health Organization (2021) Ethics and governance of artificial intelligence for health: WHO guidance. World Health Organization, Geneva. https://www.who.int/publications/i/item/9789240029200
  100. Wu, C.T., Li, G.H., Huang, C.T., et al. (2021) ‘Acute exacerbation of a chronic obstructive pulmonary disease prediction system using wearable device data, machine learning, and deep learning: development and cohort study’, JMIR mHealth and uHealth, 9, e22591. https://doi.org/10.2196/22591
  101. Yang, X. (2024) ‘Application and prospects of artificial intelligence technology in early screening of chronic obstructive pulmonary disease at primary healthcare institutions in China’, International Journal of Chronic Obstructive Pulmonary Disease, 19, pp. 1061-1067. https://doi.org/10.2147/COPD.S458935
  102. Young, A.L., Bragman, F.J.S., Rangelov, B., et al. (2020) ‘Disease progression modeling in chronic obstructive pulmonary disease’, American Journal of Respiratory and Critical Care Medicine, 201, pp. 294-302. https://doi.org/10.1164/rccm.201908-1600OC
  103. Yun, J., Cho, Y.H., Lee, S.M., et al. (2021) ‘Deep radiomics-based survival prediction in patients with chronic obstructive pulmonary disease’, Scientific Reports, 11, 15144. https://doi.org/10.1038/s41598-021-94535-4
  104. Zech, J.R., Badgeley, M.A., Liu, M., et al. (2018) ‘Variable generalization performance of a deep learning model to detect pneumonia in chest radiographs: a cross-sectional study’, PLoS Medicine, 15(11), e1002683. https://doi.org/10.1371/journal.pmed.1002683
  105. Zeng, S., Arjomandi, M., Tong, Y., et al. (2022) ‘Developing a machine learning model to predict severe chronic obstructive pulmonary disease exacerbations: retrospective cohort study’, Journal of Medical Internet Research, 24, e28953. https://doi.org/10.2196/28953

Rajshahi Medical College and University of Rajshahi, BANGLADESH.



Royal Melbourne Institute of Technology (RMIT), Melbourne, AUSTRALIA.




Agri. Services, Islamabad Model College for Girls, and Riphah International University, PAKISTAN.




Kampala International University, UGANDA; Rivers State University, NIGERIA.